TCRT icon

Alaunos Therapeutics

124 hedge funds and large institutions have $241M invested in Alaunos Therapeutics in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

9% less funds holding

Funds holding: 137124 (-13)

57% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 23

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
124
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.96M
Puts
$5.23M
Net Calls
Net Calls Change

Top Buyers

1 +$17.3M
2 +$6.76M
3 +$1.74M
4
State Street
State Street
Massachusetts
+$1.43M
5
Rafferty Asset Management
Rafferty Asset Management
New York
+$806K

Top Sellers

1 -$8.16M
2 -$1.42M
3 -$1.19M
4
UBS Group
UBS Group
Switzerland
-$1.14M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$991K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$727K
27
$713K
28
$713K
29
$698K
30
$681K
31
$666K
32
$595K
33
$510K
34
$486K
35
$441K
36
$439K
37
$430K
38
$393K
39
$369K
40
$360K
41
$355K
42
$354K
43
$346K
44
$344K
45
$341K
46
$334K
47
$323K
48
$315K
49
$300K
50
$289K